Published Manuskript Version 1
LHA ID: 8H3139WTTY-3
Filename:
fimmu-13-994885.pdf
Format: PDF document
Size: 11.1 MB
Data file type: Not specified
Human Diseases: No Human Disease specified
Export PNG
Creators and Submitter
Views: 897 Downloads: 45
Created: 31st Mar 2023 at 16:29
Last used: 18th Apr 2024 at 20:21
TagsThis item has not yet been tagged.
AttributionsNone
Version History
Version 1 Created 31st Mar 2023 at 16:29 by Henry Löffler-Wirth
No revision comments
Related items
The vision of Immune Safety Avatar (imSAVAR) is to develop a platform for integrated nonclinical assessments of immunomodulatory therapy safety and efficacy.The imSAVAR is an Innovative Medicines Initiative funded project that aims to develop a standard for integrated nonclinical safety overviews for immune-modulatory investigational new drugs (IND) and clinical trial applications (CTA).Our imSAVAR platform will improve the prediction of the transferability of safety and efficacy of immunomodulators ...
Programme: European Union’s Horizon 2020
Public web page: https://imsavar.eu/
Abstract (Expand)
Authors: H. Loeffler-Wirth, M. Rade, A. Arakelyan, M. Kreuz, M. Loeffler, U. Koehl, K. Reiche, H. Binder
Date Published: 17th Oct 2022
Publication Type: Journal article
Projects: Leipzig Melanoma Studies, GLA - German Lymphoma Alliance, MMML-MYC-SYS, GGN - German Glioma Network, LIFE Adult, LIFE - Leipzig Research Center for Civilization Diseases, Task Force COVID-19 Leipzig, NFDI4Health, LHA - Leipzig Health Atlas, Think different, imSAVAR - Immune safety avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies, oBIG - omics Bioinformatics for Health
Institutions: University of Leipzig, Interdisciplinary Center for Bioinformatics (IZBI)
https://orcid.org/0000-0001-8239-440X
Web page: Not specified
